SKI Market

A+| A| A-|

Indian Indices

Sensex

73,583.22 -1,690.23
( -2.25%)

Global Indices

Nasdaq

45,202.56 -778.56
(-1.69%)

Dow Jones

6,394.42 -103.74
(-1.60%)

Hang Seng

53,412.46 -191.19
(-0.36%)

Nikkei 225

9,959.27 -12.90
(-0.13%)

Forex

USD-INR

94.09 0.23
(0.24%)

EUR-INR

108.64 -0.12
(-0.11%)

GBP-INR

125.57 -0.09
(-0.07%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nephro Care India Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

92991

INE0SUN01013

32.4415882

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NEPHROCARE

30.06

86.22

EPS(TTM)

Face Value()

Div & Yield %

1.74

Back

Indrayani Biotech Ltd - Announcement Under Regulation 30 Of SEBI LODR With Regard To Approval Of Category II AIF

Sep 16,2025

The Companys Wholly owned subsidiary IBL Investment Limited has received approval from SEBI for Category II Alternate Investment Fund Registration

73,583.22 -1,690.23 ( -2.25%)

45,202.56 -778.56 (-1.69%)

6,394.42 -103.74 (-1.60%)

53,412.46 -191.19 (-0.36%)

9,959.27 -12.90 (-0.13%)

94.09 0.23 (0.24%)

108.64 -0.12 (-0.11%)

125.57 -0.09 (-0.07%)

0.59 0.00 (-0.07%)